Navigation Links
OncoGenex receives completed Special Protocol Assessment for primary registration study of lead drug candidate OGX-011
Date:7/14/2008

other than statements of historical fact are statements that could be deemed forward-looking statements. For example, statements of the results of clinical studies, the timing of clinical trials and development efforts and the timing of closing the proposed merger are all forward-looking statements. The potential risks and uncertainties include, among others, that clinical results will not be maintained in final data analysis, that current or future clinical trials will not be successful or confirm the results of earlier studies, risks related to the timing and costs of clinical trials and regulatory approvals, risks associated with obtaining funding from third parties or completing a financing necessary to support the costs and expenses of clinical studies, risks relating to the development, safety and efficacy of therapeutic drugs and potential applications for these products and the possibility that the merger with Sonus does not close or that the closing may be delayed. No assurances can be given that any of the events anticipated by the forward-looking statements will transpire or occur, or if any of them do so, what impact they will have on the results of operations or financial condition of OncoGenex. The Company undertakes no obligation to update the forward-looking statements contained herein or to reflect events or circumstances occurring after the date hereof.

Proxy Solicitation

In connection with the proposed merger, Sonus filed with the SEC a Proxy Statement and related materials on July 3, 2008 containing information about Sonus, OncoGenex and the proposed merger. Sonus mailed the Proxy Statement to its stockholders on or about July 9, 2008. INVESTORS AND SECURITY HOLDERS ARE URGED TO READ THE PROXY STATEMENT AND THE OTHER RELEVANT MATERIALS, CAREFULLY AND IN THEIR ENTIRETY, BECAUSE THEY CONTAIN IMPORTANT INFORMATION ABOUT SONUS, ONCOGENEX AND THE PROPOSED MERGER.

Sonus and OncoGenex, and certain of their directors, executive offi
'/>"/>

SOURCE OncoGenex Technologies Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. OncoGenex increases economic interest in lead cancer drug OGX-011
2. OncoGenex to present at the Needham & Company 7th Annual Biotechnology & Medical Technology Conference
3. Sonus Pharmaceuticals and OncoGenex Technologies to Merge
4. OncoGenex reports lead drug candidate OGX-011 achieved primary endpoint in Phase 2 Trial with second-line chemotherapy for prostate cancer
5. CV Therapeutics Receives European Marketing Authorization for Ranolazine for the Treatment of Patients With Chronic Angina
6. Epeius Biotechnologies Tumor-Targeted Rexin-G Receives FDA Orphan Drug Designation for the Treatment of Osteosarcoma
7. Edison Pharmaceuticals Receives Commendation From the City of San Jose
8. GeneraMedix Inc. Receives Approval for Epoprostenol for Injection 1.5 mg
9. Microfluidic Systems Receives Continued Funding From the Department of Homeland Security (DHS) Toward the Commercial Production of Autonomous Airborne Pathogen Detection Systems
10. Par Pharmaceutical Receives Final Approval to Market Generic Marinol(R) CIII (Dronabinol) Capsules
11. Indevus Receives Approvable Letter from FDA for NEBIDO(R)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/14/2014)... pet owners drew up their lists of New Year,s resolutions for ... of my furry companion." Nowadays there are pet salons, dog and ... take the little canine or feline darlings along wherever mommy or ... pricey toys at the pet store. But anyone who has ever ...
(Date:1/14/2014)... Md. , Jan. 14, 2014  Organovo announced today ... the National Institutes of Health (NIH) to help scientists ... treatments to patients on a faster timeline. Organovo is ... (NCATS) and the National Eye Institute (NEI) to develop ...
(Date:1/14/2014)... , Jan. 14, 2014  RXi Pharmaceuticals Corporation ... developing and commercializing innovative therapies addressing major unmet ... it received the Notice of Allowance from the ... unique self-delivering RNAi compounds (sd-rxRNA®), for the treatment ...
(Date:1/14/2014)... January 13, 2014 Bob Hainsey, a ... than 20 years in the industry, has joined ... Hainsey will serve as the society’s Science and Technology ... join SPIE as our Technology Strategist, further strengthening the ...
Breaking Biology Technology:New Year's Resolution: Give Pets the Gift of Top-Notch Health Care 2Organovo Announces Collaboration with National Institutes of Health 2Organovo Announces Collaboration with National Institutes of Health 3RXi Pharmaceuticals Receives US Notice of Allowance for a Key Patent Relating to its Self-Delivering Technology with sd-rxRNAs targeting CTGF, including RXI-109, for the Treatment of Fibrotic Disorders 2RXi Pharmaceuticals Receives US Notice of Allowance for a Key Patent Relating to its Self-Delivering Technology with sd-rxRNAs targeting CTGF, including RXI-109, for the Treatment of Fibrotic Disorders 3Photonics R&D Leader Bob Hainsey Joins SPIE Technical Staff 2
... , , , , , , ... Eppendorf 5 Prime, Inc., , , , , ... gDNA Blood Mini Kit is an efficient way to purify genomic , ... In addition, it has been shown that the kit can also be used to ...
... , , , , , ... Eppendorf 5 Prime, Inc. , , , , ... Buccal swabs are the least invasive way of collecting gDNA from humans, , ... , pathogens. Buccal swabs are quickly becoming the method of ...
... , E-mail us your application notes for inclusion in this Eppendorf web page. , ... cuvettes. , , , , ... Bacteria, gram negative , , ... href="http://www.biocompare.com/techart.asp?id=575">Actinobacillus , ...
Cached Biology Technology:Genomic DNA Extraction from Buffy Coat Using the Perfect gDNA Blood , Mini Kit 2Genomic DNA Extraction from Buffy Coat Using the Perfect gDNA Blood , Mini Kit 3Genomic DNA Extraction from Buffy Coat Using the Perfect gDNA Blood , Mini Kit 4Genomic DNA Extraction from Buffy Coat Using the Perfect gDNA Blood , Mini Kit 5Genomic DNA Extraction from Buffy Coat Using the Perfect gDNA Blood , Mini Kit 6Genomic DNA Extraction from Buffy Coat Using the Perfect gDNA Blood , Mini Kit 7Genomic DNA Extraction from Buffy Coat Using the Perfect gDNA Blood , Mini Kit 8Genomic DNA Extraction from Buccal Swabs Using the Perfect gDNA Blood , Mini Kit 2Genomic DNA Extraction from Buccal Swabs Using the Perfect gDNA Blood , Mini Kit 3Genomic DNA Extraction from Buccal Swabs Using the Perfect gDNA Blood , Mini Kit 4Genomic DNA Extraction from Buccal Swabs Using the Perfect gDNA Blood , Mini Kit 5Eppendorf Electroporation Application Notes Your participation , is highly welcome !!! 2Eppendorf Electroporation Application Notes Your participation , is highly welcome !!! 3Eppendorf Electroporation Application Notes Your participation , is highly welcome !!! 4Eppendorf Electroporation Application Notes Your participation , is highly welcome !!! 5
(Date:7/9/2014)... refers to species, selection for traits that are attractive ... selection enhances opportunities to mate, the tail of male ... University of California, Riverside have now found that sexual ... are linked. Describing the life histories of more ... the researchers found that species with placentas tend to ...
(Date:7/9/2014)... from the oils produced by algae may offer a ... goal, optimization of cost effective strategies for large-scale algae ... Sapphire Energy has developed an innovative solution to the ... described in Industrial Biotechnology , a peer-reviewed journal ... available on the Industrial Biotechnology website ...
(Date:7/9/2014)... of Guelph scientist that involved fitting bumblebees with ... a neonicotinoid pesticide hampers bees, ability to forage ... a professor in Guelph,s School of Environmental Sciences, ... published July 9 in the British Ecological Society,s ... shows how long-term pesticide exposure affects individual bees, ...
Breaking Biology News(10 mins):Biologists link sexual selection and placenta formation 2Biologists link sexual selection and placenta formation 3Biologists link sexual selection and placenta formation 4Controlling contamination in open algae ponds for biofuels 2Bee foraging chronically impaired by pesticide exposure: Study 2
... change is already having a detectable impact on birds ... team publishing their findings to create the world,s first ... a continental scale. Published in the journal ... Royal Society for the Protection of Birds have shown ...
... climate change projected this century for Oregon,s Upper ... supplies, buildings, transportation systems, human health, forests, and ... by the University of Oregon,s Climate Leadership Initiative ... Policy. The authors say that extensive efforts ...
... DNA in the nucleus of each of our cells is converted ... serve as coding templates for the synthesis of proteins. Of the ... scant few are known: they inhibit the activity of genes or ... within cells. What the rest of them do within cells is ...
Cached Biology News:Climate change affecting Europe's birds now, say researchers 2Climate change affecting Europe's birds now, say researchers 3Eugene-Springfield face Upper Willamette climate threats 2Eugene-Springfield face Upper Willamette climate threats 3Eugene-Springfield face Upper Willamette climate threats 4CSHL researchers pinpoint structure-building role for 2 non-coding RNAs 2CSHL researchers pinpoint structure-building role for 2 non-coding RNAs 3
... (M-MLV RT) is an RNA-dependent DNA polymerase that ... messenger RNA templates (>5kb). The enzyme is a ... consists of a single subunit with a molecular ... M-MLV RT is weaker than the commonly used ...
... the determination of digitonin and digoxin. Physical form: ... 4 and 0.06% NaCl Preparation Note: Sodium ... Biophys. Res. Commun., 19, 755 (1965). Unit ... inorganic phosphorus from ATP per min at pH ...
kismet (dK-20)...
... design allows "4 gels in one tank",electrophoresis. ... to run 200,samples or more in one ... four,horizontal gels. To ensure even migration, the ... of gels being run. Ideal for,high throughput ...
Biology Products: